The world is closer to understanding the causes of ALS. However, the most important power source in the fight to find medicine these days is…patients themselves. As never before, patients are getting involved with their neurologists, providing them with blood and skin samples, their natural histories, and other critical information, all of which will lead to treatments. Even five years ago, ALS researchers couldn’t learn too much from patient samples. That has changed, with major advances in ALS research and technology. Thanks to the recent participation of people living with ALS, experts have discovered new ALS genes…a host of new therapeutic targets…and the ability to create stem cell models of ALS, or ALS in a Dish, which they can use to study a particular patient’s disease. Last month, Project ALS kicked off the ALS Living Library at Massachusetts General Hospital. Dr. James Berry directs the efforts to catalog, characterize and share with researchers, data from samples donated by ALS patients. In a related effort, Dr. Neil Shneider, director of the ALS clinic at Columbia in New York, has kicked off a study of families touched by ALS. For more information on how your family can participate in research, please contact Project ALS.
(photo: Dr. James Berry leading efforts to involve their patients in research.)
On June 3rd, AB Science announced that they were putting all clinical studies of their lead compound masitinib—including a Phase 3 trial in ALS—on voluntary